Your search returned 16 studies:
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: La Porte, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Elkhart, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Elkhart, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Michigan City, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Westville, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Elkhart, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Mishawaka, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Mishawaka, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Plymouth, Indiana
- Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent Urethral Cancer - Regional Tr
Location: South Bend, Indiana
- Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent Urethral Cancer - Regional Tr
Location: Saint Joseph, Michigan
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: South Bend, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: South Bend, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: South Bend, Indiana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Saint Joseph, Michigan
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: St. Joseph, Michigan
|